RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in RVL Pharmaceuticals plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q3 2021
- Shares held
- 17.3M
- +13.3M (+329.2%) vs. Q3 2021
- Total value
- $18.7M
- +$6.80M (+57.3%) vs. Q3 2021
- New holders
- 8
- 6 more added
- Sold out
- 12
- 12 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 1 | $0 | 0.00% | −6,213−100.0% | Reduced |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | −4,250−99.9% | Reduced |
| Advisor Group Holdings, Inc. | 1,187 | $1.00K | 0.00% | −500−29.6% | Reduced |
| The PNC Financial Services Group, Inc. | 700 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,685 | $2.00K | 0.00% | −6,163−78.5% | Reduced |
| Royal Bank of Canada | 2,386 | $2.00K | 0.00% | +455+23.6% | Added |
| Huntington National Bank | 1,650 | $2.00K | 0.00% | +1,650 | New |
| Simplex Trading, LLC | 2,298 | $2.00K | 0.00% | +2,298 | New |
| UBS Group AG | 2,772 | $3.00K | 0.00% | −2,216−44.4% | Reduced |
| Bank of New York Mellon Corp | 12,078 | $13.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 23,750 | $25.0K | 0.00% | +6,740+39.6% | Added |
| Zebra Capital Management LLC | 24,384 | $26.0K | 0.04% | 00.0% | Unchanged |
| Insight Advisors, LLC | 24,800 | $27.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 34,184 | $37.0K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 42,810 | $46.0K | 0.00% | +16,890+65.2% | Added |
| Millennium Management LLC | 43,560 | $47.0K | 0.00% | −84,003−65.9% | Reduced |
| Northern Trust Corp | 45,390 | $49.0K | 0.00% | +19,233+73.5% | Added |
| Two Sigma Advisers, LP | 63,200 | $68.0K | 0.00% | +63,200 | New |
| Deutsche Bank AG | 70,524 | $76.0K | 0.00% | −579−0.8% | Reduced |
| Dimensional Fund Advisors LP | 72,623 | $78.0K | 0.00% | −2,155−2.9% | Reduced |
| Titleist Asset Management, Ltd. | 80,184 | $87.0K | 0.02% | +80,184 | New |
| Geode Capital Management, LLC | 143,662 | $155.0K | 0.00% | −2,770−1.9% | Reduced |
| BlackRock Inc. | 157,872 | $172.0K | 0.00% | −12,630−7.4% | Reduced |
| Vanguard Group Inc | 207,942 | $225.0K | 0.00% | −2,492−1.2% | Reduced |
| Two Sigma Investments, LP | 249,851 | $270.0K | 0.00% | +249,851 | New |
| ArrowMark Colorado Holdings LLC | 1,000,000 | $1.08M | 0.01% | +1,000,000 | New |
| Alyeska Investment Group, L.P. | 1,125,689 | $1.22M | 0.01% | +1,125,689 | New |
| Renaissance Technologies LLC | 1,355,774 | $1.46M | 0.00% | +438,725+47.8% | Added |
| Morgan Stanley | 1,366,028 | $1.48M | 0.00% | −56,747−4.0% | Reduced |
| Rovida Advisors Inc. | 3,000,000 | $3.21M | 0.14% | +2,436,447+432.3% | Added |
| Athyrium Capital Management, LP | 8,148,832 | $8.80M | 3.14% | +8,148,832 | New |
| Ergoteles LLC | 0 | $0 | 0.00% | −41,349−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −27,120−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,866−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −13,434−100.0% | Sold out |
| Nations Financial Group Inc, | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,526−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,425−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,299−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,440−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −140−100.0% | Sold out |